Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Learn what index values indicate and how to use them to gauge market direction, volatility, and relative strength in your analysis.
8,600 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A growing chorus of analysts says the AI boom could lift nvidia stock will trade into the higher end of its range by ...
SpaceX could be the market's most talked-about IPO. This guide breaks down what to know, how to evaluate the opportun...
Cerebras has burst onto the Nasdaq scene, and Wall Street quickly weighed in with buys and cautious optimism. This ar...
Investors are always on the hunt for the next big winner. When a software stock looks beaten-down, opportunities and ...
A $650,000 portfolio could potentially cover a yearly luxury trip if the income approach is right, balancing high-yie...
A UFC fan event near the White House sparked headlines about an arrest, but authorities clarified there was none. Thi...
A federal judge in Illinois denied CoStar's bid to join the Zillow-MRED-Compass dispute as an amicus. The ruling may ...
Matter Labs is restructuring its workforce as it doubles down on Prividium, a permissioned privacy chain for financia...
A $50 million real estate deal nearly unraveled after both sides leaned on ChatGPT for pricing guidance. The episode ...
A growing number of retirees are turning to dividend-focused strategies to replace portions of earned income. This di...
A Father's Day post from Kris Jenner shines a spotlight on blended families, ex-partners and wealth. Here's what it t...